Mining for crypto protection: a search for Cryptosporidium antibodies reveals antigens associated with immunity
Open Access
- 15 August 2023
- journal article
- editorial
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (16)
Abstract
Infectious diarrhea is a major cause of morbidity and mortality, particularly for children in low- and middle-income countries. Cryptosporidium is a diarrheal pathogen for which there is no vaccine and current therapies are only partially effective. In this issue of the JCI, Gilchrist, Campo, and colleagues surveyed a large cohort of Bangladeshi children to profile antibody responses against an array of Cryptosporidium proteins. They discovered 233 proteins to which children developed antibodies, identified seven as being associated with protection from reinfection, and provided insights regarding the longevity of Cryptosporidium antibodies and the development of antibody breadth. In this commentary, we discuss the burden of disease caused by Cryptosporidium and how these studies highlight the strategies to better manage this parasite.Keywords
This publication has 27 references indexed in Scilit:
- Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way ForwardClinical Infectious Diseases, 2016
- Effect of rotavirus vaccine on childhood diarrhea mortality in five Latin American countriesVaccine, 2015
- Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control studyThe Lancet, 2013
- A Systematic Review of Anti-Rotavirus Serum IgA Antibody Titer as a Potential Correlate of Rotavirus Vaccine EfficacyThe Journal of Infectious Diseases, 2013
- Ending of preventable deaths from pneumonia and diarrhoea: an achievable goalThe Lancet, 2013
- High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trialBMC Infectious Diseases, 2009
- Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trialThe Lancet, 2002
- Treatment of Diarrhea Caused byCryptosporidium parvum:A Prospective Randomized, Double‐Blind, Placebo‐Controlled Study of NitazoxanideThe Journal of Infectious Diseases, 2001
- A 23-kDa Recombinant Antigen of Cryptosporidium parvum Induces a Cellular Immune Response on in Vitro Stimulated Spleen and Mesenteric Lymph Node Cells from Infected MiceExperimental Parasitology, 2000
- Longitudinal Study ofCryptosporidiumInfection in Children in Northeastern BrazilThe Journal of Infectious Diseases, 1999